权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Ultrasound-Assisted AQP1 Gene Therapy for Functional Restoration of Salivary Glan

超声辅助 AQP1 基因治疗唾液腺功能恢复

基本信息

批准号：
8668774
负责人：
Michael J. Passineau
金额：
$ 45.74万
依托单位：
ALLEGHENY-SINGER RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2012
资助国家：
美国
起止时间：
2012-07-20 至 2016-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8668774
关键词：
AQP1 gene Acinar Cell Acupuncture procedure Adenovirus Vector Adenoviruses Affect Animals Cancer Survivor Capsid Cell Therapy Chromatography Chronic Clinical Clinical Trials Complex Complication Contralateral Deglutition Dependovirus Development Devices Disease Eating Equipment FDA approved Family suidae Gene Expression Gene Transfer Gene Transfer Techniques Generations Genes Gland Goals Head and neck structure Hereditary Disease Human Immune response Injury Ionizing radiation Laboratories Life Maintenance Mass Spectrum Analysis Measures Mediating Methodology Methods Metric Microbubbles Miniature Swine Modeling Mus Non-Viral Vector Opportunistic Infections Oral Oral cavity Outpatients Patients Pharmaceutical Preparations Plasmids Procedures Proteome Proteomics Publishing Quality of life Radiation Rattus Rehydrations Relative (related person)Reporting Research Design Retreatment Saliva Salivary Salivary Glands Scanning Secondary to Sialadenitis Sjogren&apos s Syndrome Structure System Techniques Technology Testing Tooth Loss Toxic effect Ulcer Ultrasonography Validation Viral Viral Vector Work Xerostomia advanced system base clinical application conventional therapy design functional improvement functional restoration gel electrophoresis gene therapy gene therapy clinical trial improved indexing insight man next generation novel public health relevance restoration saliva proteome sonoporation success therapeutic transgene two-dimensional water channel

项目摘要

DESCRIPTION (provided by applicant): We have recently reported the development of an ultrasound-assisted gene transfer (UAGT) method in the salivary gland. This technique enables transient, non-invasive, non-viral gene transfer to the salivary gland using "off the shelf" FDA-approved microbubbles and clinical ultrasonography equipment. We submit that this technology may prove enabling for applications in gene therapy for Xerostomia given the limitations of viral vector systems, which include sialoadenitis and consequent hyposalivation. Considering the substantial prior work that has been performed in miniature swine as a close-to- man model of salivary gland function, our first aim will be to upscale our UAGT technique in miniature swine and index resultant gene expression to viral vectors. The overall goal of this first aim will be to show equivalence to viral vectors, thereby providing a rationale for their replacement. We will also test in our system an advanced-generation (minicircle) plasmid with the putative capability of longer-lasting gene expression following non-viral gene transfer. Our next step will be to undertake a restorative gene therapy treatment in our swine subjects utilizing Aquaporin-1 (AQP1), the therapeutic transgene that has shown salivary restorative promise in an ongoing human gene therapy clinical trial. UAGT and viral methods will be utilized in parallel, with primary experimental metrics being functional, namely salivary flow. Animals will be irradiated according to previously published methodologies. AQP1 treatment with viral vectors (Adenovirus and Adeno- associated virus) will be undertaken as previously described and will serve as an index by which to measure the efficacy of our UAGT-based AQP1 gene therapy. In contrast to earlier studies, we will endeavor retreatment when salivary flow declines to <20% of that in the contralateral (control) gland, with our goal being maintenance of functional improvement for 12 months. We will thereby test our hypothesis that UAGT will enable chronic maintenance of restorative gene therapy through retreatment, whereas viral vectors will not. In our final aim, we will explore an important but heretofore unaddressed issue, that of the proteomic quality of saliva produced by AQP1 gene therapy. To do this, we will undertake full- proteome profiling of the saliva produced in our animal subjects with AQP1 gene therapy, compared with saliva from non-irradiated swine and irradiated swine wherein partial sparing of the salivary gland has occurred. Scans will be performed using 2-dimensional difference gel electrophoresis, supplemented by multi- dimensional chromatography and mass spectrometry methods.

描述（由申请人提供）：我们最近报告了唾液腺超声辅助基因转移（UAGT）方法的发展。该技术使用“现成的”fda批准的微泡和临床超声设备，可以将瞬时、非侵入性、非病毒基因转移到唾液腺。我们认为，鉴于病毒载体系统的局限性，包括涎腺炎和随之而来的唾液分泌不足，该技术可能被证明能够应用于口干病的基因治疗。考虑到大量的前期工作已经在小型猪身上进行，作为一个接近人类的唾液腺功能模型，我们的第一个目标将是在小型猪身上升级我们的UAGT技术，并将所得基因表达指数化为病毒载体。第一个目标的总体目标是